Alcon AG | ALC - Loan Capital


Alcon AG reported $4.16B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AstraZeneca USD 26.01B 46M Jun/2026
Bayer EUR 30.68B 1.15B Mar/2026
Essilor EUR 9.66B 190M Jun/2026
Fresenius EUR 9.55B 1.24B Jun/2026
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
GRIFOLS EUR 7.17B 1.91B Jun/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.49B 42M Jun/2026
Philips EUR 6.32B 575M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
Smith & Nephew USD 3.21B 85M Jun/2026
Sonova Holding CHF 1.39B 209.8M Jun/2025
UCB EUR 2.18B 634M Dec/2025